BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3565076)

  • 1. Fibrinogen degradation products do not affect the hypertensive action of dopamine.
    Buczko W; Wiśniewski K
    Acta Med Pol; 1986; 27(1-2):31-6. PubMed ID: 3565076
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fibrinopeptides A and B on the circulatory action of dopamine.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):285-92. PubMed ID: 6664936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examinations on contribution of bradykinin in the action of dopamine in circulatory system of rats. I. Influence of bradykinin in the action of dopamine on arterial blood pressure of rats.
    Fiedorowicz R; Moniuszko-Jakoniuk J; Wiśniewski K
    Arch Immunol Ther Exp (Warsz); 1983; 31(5):739-48. PubMed ID: 6675575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological effect of fibrin/fibrinogen degradation products].
    Li SQ
    Sheng Li Ke Xue Jin Zhan; 1986 Apr; 17(2):169-72. PubMed ID: 3538403
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen fragments X, Y, D and E increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats.
    Princen HM; Moshage HJ; Emeis JJ; de Haard HJ; Nieuwenhuizen W; Yap SH
    Thromb Haemost; 1985 Apr; 53(2):212-5. PubMed ID: 4024030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA; del Arco C; Pazos A; Flórez J
    Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relevance of fibrinogen/fibrin degradation products in the study of thrombosis].
    Páramo JA; Gaffney PJ
    Sangre (Barc); 1989 Dec; 34(6):497-501. PubMed ID: 2697948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of fibrin-fibrinogen degradation products in the pathogenesis of a coagulopathy in leukemias].
    Krasik IaD; Fedorova ZD; Elizarova AI; Rozanova LM; Bazhenov EL
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):13-8. PubMed ID: 6929066
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of plasma fibronectin on the response to infusion of thrombin and adenosine diphosphate.
    Kaplan JE; Snedeker PW; Baum SH; Moon DG; Minnear FL
    Thromb Haemost; 1983 Jun; 49(3):217-23. PubMed ID: 6879510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the biological properties of some fibrinogen degradation products (FDP)].
    Malofiejew M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968; 23():1-65. PubMed ID: 4310706
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the role of catecholamines in the action of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):367-76. PubMed ID: 6664939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties of fibrinogen derivatives relevant to the function of cardiovascular system and immuno-inflammatory reaction.
    Kopec M
    New Istanbul Contrib Clin Sci; 1977 Sep; 12(1):43-9. PubMed ID: 565049
    [No Abstract]   [Full Text] [Related]  

  • 16. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombus formation with special reference to the substrates, fibrinogen and its related substances].
    Matsuda M
    Rinsho Ketsueki; 1984 Jul; 25(7):984-91. PubMed ID: 6502959
    [No Abstract]   [Full Text] [Related]  

  • 18. [Various aspects of the regulation and role of fibrinolysis in the organism].
    Myśliwiec M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1982; 27():21-63. PubMed ID: 6820837
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of 3-cyano-2-morpholino-5-(päyrid-4-yl)pyridine (AWD 122-14) and dopamine on left ventricular function during acute volume load in 18-month-old spontaneously hypertensive rats and Wistar-Kyoto rats.
    Rohde E; Wiesner B; Blasig IE
    Pharmazie; 1993 Sep; 48(9):687-90. PubMed ID: 8234404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertensive effect of dopamine in anesthetized rat.
    Grabowska M
    Pol J Pharmacol Pharm; 1974; 26(3):317-23. PubMed ID: 4852329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.